期刊文献+

细胞色素P450 2D6与吸烟所致肺癌易感性的关系研究 被引量:4

Relation between cytochrome P450 2D6 and lung cancer susceptibility caused by smoking
下载PDF
导出
摘要 细胞色素P450 2D6(CYP2D6)是肝脏中重要的Ⅰ相代谢酶,参与烟草中特异性亚硝胺类如4-甲基亚硝胺-1,3-吡啶基-1-丁酮(NNK)及烟碱的代谢,可能涉及吸烟引起的肺癌变过程。对其生物学特性、结构功能和基因多态与肺癌易感性的关系等方面的研究,有助于深入理解CYP2D6基因多态性对个体肺癌易感性的重要影响,并从基因-环境交互作用的角度,更好地进行危险度评价。 Cytochrome P450 2D6(CYP2D6) is one of the prominent phase 1 metabolizing enzymes in hepatic tissue, and is responsible for metabolically activating the tobacco-specific nitrosamine such as NNK and nicotinamide to highly reactive metabolites, so it may play a role in lung cancer. The study of its biological characters, structure function and the relationship beween CYP2D6 genetic polymorphisms and lung cancer susceptibility can redound to understand the significant influence of CYP2D6 on lung cancer susceptibility. Furthermore from the point of view of interaction between gene and environment it can evaluate the lung cancer risk accurately.
出处 《卫生研究》 CAS CSCD 北大核心 2007年第1期112-113,116,共3页 Journal of Hygiene Research
基金 "211工程"重点学科研究项目"肿瘤与生物工程"子项目
关键词 细胞色素P4502D6 遗传多态性 肺癌易感性 CYP2D6*10 Cytochrome P450 2D6, genetic polymorphisms, lung cancer susceptibility, CYP2D6 * 10
  • 相关文献

参考文献6

二级参考文献41

  • 1Wang S L,Clin Pharmacolr,1993年,53卷,410页
  • 2Wang SL,Huang JD,Lai MD,et al.Molecular basis of genetic variation in debrisoquine hydroxylation in chinese subjects:Polymorphism in RFLP and DNA sequence of CYP2D6[J].Clin Pharmacol Ther,1993,53:410.
  • 3Gonzalez FJ.Meyer UA. Molecular genetics of the debrisonquine sparteine polymorphism[J].Clin Pharmacol Ther,1991,50:233.
  • 4CAI Wei-min,CHEN Bing, LIU Yu-xin,et al. Dextromethorphan metalbolic phentyping in a Chinese population[J].Acta Pharmacoogica Sinisa,1997,60:177.
  • 5Anderson KE.Influence of diet and nutrition on clinical pharmacokinetics[J]. Clin Pharmacol,1991,14:325.
  • 6Johansson I,Yue QY,Dahi ML, et al. Genetic analysis of the interethnic difference between Chinese and Caucasian in the polymorphic metabolism of debrisonquine and codeine[J]. Eur Pharmacol,1991,40:553.
  • 7Evans WE, Relling MV. Concordence of CYP2D6(debrisonquine hydrolation)phenytype and genoyype:Inability of dextromethorphan metabolic ratio to discriminate reliably heterozygous and homozygous extenssive metabolizers[J]. Pharmacogenetics,1991,1:143.
  • 8Bertilsson L,Dahi ML. Polymorphic drug oxidation:Relation to the treatment of psychiatric disorders[J].CNS Drug,1996,5:200.
  • 9Evans WE,Relling MV,Rahman A,et al.Genetic basis for a lower prevalence of defient CYP2D6 oxidative drug metabolism phenotypes in black American[J]. Clin Pharmacol,1993,91:2150.
  • 10Tyndale RF,Sunahara R, Inaba T,et al. Neuronal cytochrome P4502D6(debrisonquine sqarteine-type):Potent inhibition of activity by cocaine and nucleotide sequence identity to human hepatic P450 GENE CYP2D6[J].Mol Pharmacol,1991,40:63.

共引文献53

同被引文献38

  • 1刘春莲,焦海燕.细胞色素P4501A1基因多态性及其与肿瘤易感性研究进展[J].国际遗传学杂志,2007,30(1):52-56. 被引量:3
  • 2燕贞,吴拥军,吴逸明.CYP2D6 C188T单核苷酸多态与肺癌易感性[J].环境与职业医学,2007,24(2):167-169. 被引量:5
  • 3林芬,李建英.15-脂氧合酶在肿瘤中的作用[J].国际内科学杂志,2007,34(6):343-346. 被引量:2
  • 4Yue QY, Zhong ZH, Tybring G, et al. Pharmacokinetics of nortriptyline and its 10-hydroxy metabolite in Chinese subjects of different CYP2D6 genotypes[J]. Clin Pharmacol Ther, 1998,64(4) : 384-390.
  • 5Cui YM, Teng CH, Pan AX,et al. Atomoxetine pharmacokinetics in healthy Chinese subjects and effect of the CYP2D6 *10 allele[J].Br J Clin Pharmacol, 2007,64(4) :445-449.
  • 6Saruwatari J, Matsunaga M, Ikeda K, et al. Impact of CYP2D6*10 on H1 antihistamine induced hypersomnia [J].Eur J Clin Pharmacol, 2006, 62(12) :995- 1001.
  • 7Xu Y,Sun Y,Yao L,et al. Association between CYP2D6 *10 genotype and survival of breast cancer patients receiving tamoxifen treatment[J]. Ann Oncol,2008,19(8):1423-1429.
  • 8Lira KS, Cho JY, Jang IJ, et al. Pharmacokinetic interaction of flecainide and paroxetine in relation to the CYP2D6*10 allele in healthy Korean subjects[J]. Br J Clin Pharmacol,2008, 66(6) : 660-666.
  • 9Ramamoorthy Y, Tyndale RF, Sellers EM. Cytochrome P450 2D6*1 and cytoehrome P450 2D6 *10 differ in catalytic activity for multiple substrates[J]. Pharmacogenetics, 2001,11 (6) : 477-487.
  • 10Ozturk O,Isbir T,Yaylim I,et al.GSTM1 and CYP1A1 gene polymorphism and daily fruit consumption in Turkish patients with non-small cell lung carcinomas[J].In viro,2003,17 (6):625-632.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部